Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Afatinib and Paclitaxel in Neoadjuvant TNBC
NCT02511847Phase 2Unknown
- Sponsor
- National Taiwan University Hospital
- Start
- Aug 2015
- Primary completion
- Jul 2017
- Countries
- 1
01
Overview
Phase 2, open-label trial of afatinib in triple-negative breast cancer (TNBC), sponsored by National Taiwan University Hospital. Status: unknown.
02
Drugs
afatinib
03
Conditions
triple-negative breast cancer (TNBC)
Beyond the preview
Go deeper on NCT02511847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02511847.